Dr. David Wolf will be speaking on a panel presentation about AI in Healthcare and Spektron’s unique approach to medicinal molecule design. This invite-only presentation will be attended by investors looking to learn more about AI in this industry. Hosted by IMPACTIVE BioConsult, this presentation appends the 2019 BIO CEO SUMMIT and is being held 7:00 pm at Morgan Stanley.
Seeking Strategic Partnerships
Spektron Systems seeks a few, select strategic partners with which to demonstrate, and share in the value of, Q-MAP’s powerful, AI-based Drug Discovery capacity. Spektron desires to succeed in demonstrations of:
- Quantitative High Throughput Screen Data Analysis
- Predictive Toxicity modeling and off-target identification
- ID of candidates for drug repurposing